<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Ba A</submitter><funding>NIAID NIH HHS</funding><funding>FIC NIH HHS</funding><pubmed_abstract>The &lt;i>Plasmodium falciparum&lt;/i> cysteine-rich protective antigen (PfCyRPA) is a promising target as a next-generation blood-stage malaria vaccine and together with PCRCR complex members, the reticulocyte binding-like homologous protein 5 (PfRh5) and the Rh5-interacting protein (PfRipr), are currently being evaluated in clinical trials. PfCyRPA is essential for merozoite invasion and appears to be highly conserved within the &lt;i>P. falciparum&lt;/i> parasite populations. Here, we used a targeted deep amplicon next-generation sequencing approach to assess the breadth of PfCyRPA genetic diversity in 95 &lt;i>P. falciparum&lt;/i> clinical isolates from Kédougou, an area with a high seasonal malaria transmission in Senegal. Our data show the dominant prevalence of PfCyRPA wild type reference allele, whi</pubmed_abstract><journal>medRxiv : the preprint server for health sciences</journal><pagination>2024.10.13.24305808</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11527082</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Genetic diversity in the Plasmodium falciparum next-generation blood stage vaccine candidate antigen PfCyRPA in Senegal.</pubmed_title><pmcid>PMC11527082</pmcid><funding_grant_id>R01 AI168238</funding_grant_id><funding_grant_id>K01 TW010496</funding_grant_id><pubmed_authors>Sheng Z</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Moore AJ</pubmed_authors><pubmed_authors>Patel SD</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Shapiro L</pubmed_authors><pubmed_authors>Pouye MN</pubmed_authors><pubmed_authors>Mbengue A</pubmed_authors><pubmed_authors>Diallo F</pubmed_authors><pubmed_authors>Sene SD</pubmed_authors><pubmed_authors>Laqqa S</pubmed_authors><pubmed_authors>Ndiaye JLA</pubmed_authors><pubmed_authors>Mangou K</pubmed_authors><pubmed_authors>Cisse A</pubmed_authors><pubmed_authors>Guerra N</pubmed_authors><pubmed_authors>Thiam LG</pubmed_authors><pubmed_authors>Sadio BD</pubmed_authors><pubmed_authors>Bei AK</pubmed_authors><pubmed_authors>Ba A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic diversity in the Plasmodium falciparum next-generation blood stage vaccine candidate antigen PfCyRPA in Senegal.</name><description>The &lt;i>Plasmodium falciparum&lt;/i> cysteine-rich protective antigen (PfCyRPA) is a promising target as a next-generation blood-stage malaria vaccine and together with PCRCR complex members, the reticulocyte binding-like homologous protein 5 (PfRh5) and the Rh5-interacting protein (PfRipr), are currently being evaluated in clinical trials. PfCyRPA is essential for merozoite invasion and appears to be highly conserved within the &lt;i>P. falciparum&lt;/i> parasite populations. Here, we used a targeted deep amplicon next-generation sequencing approach to assess the breadth of PfCyRPA genetic diversity in 95 &lt;i>P. falciparum&lt;/i> clinical isolates from Kédougou, an area with a high seasonal malaria transmission in Senegal. Our data show the dominant prevalence of PfCyRPA wild type reference allele, whi</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-07-02T03:15:32.045Z</modification><creation>2025-04-06T10:11:39.417Z</creation></dates><accession>S-EPMC11527082</accession><cross_references><pubmed>39484257</pubmed><doi>10.1101/2024.10.13.24305808</doi></cross_references></HashMap>